• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调强放疗后仅出现咽后淋巴结转移的鼻咽癌患者行颈部局部照射的治疗效果及可行性

Treatment outcomes and feasibility of partial neck irradiation for patients with nasopharyngeal carcinoma with only retropharyngeal lymph node metastasis after intensity-modulated radiotherapy.

作者信息

Chen Mo, Tang Ling-Long, Sun Ying, Mao Yan-Ping, Li Wen-Fei, Guo Rui, Liu Li-Zhi, Li Li, Lin Ai-Hua, Ma Jun

机构信息

Department of Radiation Oncology, State Key Laboratory of Oncology in Southern China, Cancer Center, Sun Yat-sen University, Guangzhou, People's Republic of China.

出版信息

Head Neck. 2014 Apr;36(4):468-73. doi: 10.1002/hed.23314. Epub 2013 Jun 18.

DOI:10.1002/hed.23314
PMID:23780916
Abstract

BACKGROUND

The purpose of this study was to summarize the treatment outcomes and evaluate the feasibility of partial neck irradiation in patients with nasopharyngeal carcinoma (NPC) with only retropharyngeal lymph nodes (RLNs) metastasis.

METHODS

Between January 2003 and December 2007, 54 patients with NPC who received partial neck irradiation to levels II, III, and VA and 100 patients who received whole neck irradiation were reviewed.

RESULTS

The 5-year disease free survival (DFS), disease metastasis-free survival, (DMFS) local relapse-free survival (LRFS), and regional relapse-free survival (RRFS) rates were 81.8%, 87.7%, 94.8%, and 98.1%, respectively. The 5-year RRFS and DFS rates for the partial neck irradiation group and whole neck irradiation group were 98.1% versus 98.0% (p = .882), 87.0% vs 77.0% (p = .117), respectively. Partial neck irradiation was not considered a significant prognostic factor for any endpoint in univariate and multivariate analyses.

CONCLUSION

Partial irradiation of neck levels II, III, and VA might be acceptable for patients with NPC with only RLN metastasis.

摘要

背景

本研究旨在总结仅伴有咽后淋巴结(RLNs)转移的鼻咽癌(NPC)患者的治疗结果,并评估颈部局部照射的可行性。

方法

回顾性分析2003年1月至2007年12月期间接受颈部II、III和VA区局部照射的54例NPC患者以及接受全颈照射的100例患者。

结果

5年无病生存率(DFS)、无疾病转移生存率(DMFS)、局部无复发生存率(LRFS)和区域无复发生存率(RRFS)分别为81.8%、87.7%、94.8%和98.1%。局部颈部照射组和全颈部照射组的5年RRFS和DFS率分别为98.1%对98.0%(p = 0.882)、87.0%对77.0%(p = 0.117)。在单因素和多因素分析中,局部颈部照射均未被视为任何终点的显著预后因素。

结论

对于仅伴有RLN转移的NPC患者,颈部II、III和VA区的局部照射可能是可以接受的。

相似文献

1
Treatment outcomes and feasibility of partial neck irradiation for patients with nasopharyngeal carcinoma with only retropharyngeal lymph node metastasis after intensity-modulated radiotherapy.调强放疗后仅出现咽后淋巴结转移的鼻咽癌患者行颈部局部照射的治疗效果及可行性
Head Neck. 2014 Apr;36(4):468-73. doi: 10.1002/hed.23314. Epub 2013 Jun 18.
2
Treatment outcome of nasopharyngeal carcinoma with retropharyngeal lymph nodes metastasis only and the feasibility of elective neck irradiation.仅伴有咽后淋巴结转移的鼻咽癌治疗转归及选择性颈淋巴结照射的可行性。
Oral Oncol. 2012 Oct;48(10):1045-1050. doi: 10.1016/j.oraloncology.2012.04.011. Epub 2012 May 24.
3
Comparative study on prophylactic irradiation to the whole neck and to the upper neck for patients with neck lymph node-negative nasopharyngeal carcinoma.颈部淋巴结阴性鼻咽癌患者全颈与上颈预防性照射的比较研究
Head Neck. 2014 May;36(5):687-93. doi: 10.1002/hed.23359. Epub 2013 Oct 17.
4
Is elective irradiation to the lower neck necessary for N0 nasopharyngeal carcinoma?对于 N0 期鼻咽癌,是否有必要对下颈部进行选择性放疗?
Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1397-402. doi: 10.1016/j.ijrobp.2009.06.062. Epub 2010 Jan 13.
5
The feasibility of contralateral lower neck sparing intensity modulation radiated therapy for nasopharyngeal carcinoma patients with unilateral cervical lymph node involvement.对单侧颈部淋巴结受累的鼻咽癌患者进行对侧下颈部 sparing 调强放射治疗的可行性。
Oral Oncol. 2017 Jun;69:68-73. doi: 10.1016/j.oraloncology.2017.03.010. Epub 2017 Apr 17.
6
Prognostic value and staging classification of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.调强放疗治疗鼻咽癌患者咽后淋巴结转移的预后价值及分期分类
PLoS One. 2014 Oct 10;9(10):e108375. doi: 10.1371/journal.pone.0108375. eCollection 2014.
7
Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.鼻咽癌患者颈 V 水平后区转移性淋巴结的分布模式与预后。
BMC Cancer. 2020 Jul 17;20(1):667. doi: 10.1186/s12885-020-07146-z.
8
Incidence of small lymph node metastases in patients with nasopharyngeal carcinoma: Clinical implications for prognosis and treatment.鼻咽癌患者小淋巴结转移的发生率:对预后和治疗的临床意义
Head Neck. 2017 Feb;39(2):305-310. doi: 10.1002/hed.24586. Epub 2016 Sep 14.
9
Treatment results of 59 young patients with nasopharyngeal carcinoma.59例年轻鼻咽癌患者的治疗结果
Int J Pediatr Otorhinolaryngol. 2005 Feb;69(2):201-7. doi: 10.1016/j.ijporl.2004.09.001.
10
Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: prognostic value and staging categories.鼻咽癌的咽后淋巴结转移:预后价值及分期类别
Clin Cancer Res. 2007 Mar 1;13(5):1445-52. doi: 10.1158/1078-0432.CCR-06-2059.

引用本文的文献

1
Feasibility of elective neck irradiation in treating node-negative nasopharyngeal carcinoma patients: a meta-analysis.选择性颈部放疗治疗淋巴结阴性鼻咽癌患者的可行性:一项荟萃分析。
Front Oncol. 2025 May 22;15:1456724. doi: 10.3389/fonc.2025.1456724. eCollection 2025.
2
Current Status and Future Directions of Proton Therapy for Head and Neck Carcinoma.头颈部癌质子治疗的现状与未来方向
Cancers (Basel). 2024 May 30;16(11):2085. doi: 10.3390/cancers16112085.
3
Recurrence risk stratification based on Epstein-Barr virus DNA to identify enlarged retropharyngeal lymph nodes of nasopharyngeal carcinoma: A model-histopathologic correlation study.
基于爱泼斯坦-巴尔病毒DNA的复发风险分层以识别鼻咽癌的咽后淋巴结肿大:一项模型-组织病理学相关性研究。
Front Med (Lausanne). 2022 Dec 1;9:996127. doi: 10.3389/fmed.2022.996127. eCollection 2022.
4
[Is elective irradiation of lymph node levels IV and Vb necessary in nasopharyngeal carcinoma?].[鼻咽癌中对IV和Vb级淋巴结进行选择性照射是否必要?]
Strahlenther Onkol. 2022 Nov;198(11):1042-1044. doi: 10.1007/s00066-022-01986-3. Epub 2022 Aug 11.
5
Lower-Neck Sparing Using Proton Therapy in Patients with Uninvolved Neck Nasopharyngeal Carcinoma: Is It Safe?未累及颈部的鼻咽癌患者采用质子治疗保留下颈部:安全吗?
J Clin Med. 2022 Jun 9;11(12):3297. doi: 10.3390/jcm11123297.
6
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma.中国临床肿瘤学会(CSCO)鼻咽癌诊断与治疗临床指南。
Cancer Commun (Lond). 2021 Nov;41(11):1195-1227. doi: 10.1002/cac2.12218. Epub 2021 Oct 26.
7
Contralateral Lower Neck Sparing Radiotherapy in Stage N1 Nasopharyngeal Carcinoma: Long-Term Survival Outcomes and Late Toxicities.N1期鼻咽癌对侧下颈部保留放疗:长期生存结果和晚期毒性
Front Oncol. 2021 Feb 25;11:628919. doi: 10.3389/fonc.2021.628919. eCollection 2021.
8
RNAi-mediated knockdown of PFK1 decreases the invasive capability and metastasis of nasopharyngeal carcinoma cell line, CNE-2.RNAi 介导的 PFK1 基因敲低降低鼻咽癌细胞系 CNE-2 的侵袭和转移能力。
Cell Cycle. 2021 Jan;20(2):154-165. doi: 10.1080/15384101.2020.1866279. Epub 2021 Jan 6.
9
Feasibility of ipsilateral lower neck sparing irradiation for unilateral or bilateral neck node-negative nasopharyngeal carcinoma: systemic review and meta-analysis of 2, 521 patients.单侧或双侧颈部淋巴结阴性鼻咽癌同侧下颈部免于照射的可行性:2521 例患者的系统评价和荟萃分析。
Radiat Oncol. 2018 Aug 6;13(1):141. doi: 10.1186/s13014-018-1087-x.
10
The efficacy and toxicity of individualized intensity-modulated radiotherapy based on the tumor extension patterns of nasopharyngeal carcinoma.基于鼻咽癌肿瘤扩展模式的个体化调强放疗的疗效与毒性
Oncotarget. 2016 Apr 12;7(15):20680-90. doi: 10.18632/oncotarget.8004.